English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsMedplus

    Medplus

    Jump to
    • MedPlus’s generic drug push is yielding tangible benefits

      MedPlus’s generic drug push is yielding tangible benefits

      Traction in private label business has infused positive momentum into MedPlus’s stock

    • MedPlus’ own branded product business needs close monitoring by investors

      MedPlus’ own branded product business needs close monitoring by investors

      Success of the private label pharma products can improve MedPlus’ profitability and accelerate generic drug adoption in India

    • Why Jefferies sees 50% upside in a healthcare distributor that listed at a discount

      Why Jefferies sees 50% upside in a healthcare distributor that listed at a discount

      The brokerage, initiating coverage on the stock with a buy recommendation, said that the company is well placed to deliver an organic revenue growth that is 2x the industry's pace over FY24-26E.

    • MedPlus to sell over 500 off-patent drugs at huge discounts

      MedPlus to sell over 500 off-patent drugs at huge discounts

      G Madhukar Reddy, managing director and chief executive officer, MedPlus, in a press conference here said the company tied up with multiple reputed pharmaceutical manufacturing companies to produce high quality off-patent medicines that enables the firm to pass on the benefit to the consumer.

    • Tata 1mg plans rapid offline foray by end of year

      Tata 1mg plans rapid offline foray by end of year

      The company, which has about 50 stores in Gurugram, Jaipur, Delhi, Noida and Kolkata, is gearing up to expand its brick-and-mortar base to about 200-300 stores by the end of 2023, after setting up shops in Bengaluru, Hyderabad and Mumbai.

    • Gainers & Losers: 10 stocks that moved the most on December 29

      Gainers & Losers: 10 stocks that moved the most on December 29

      About 1813 shares advanced, 1562 shares declined, and 141 shares were unchanged on December 29

    • Warburg Pincus and PremjiInvest-Backed MedPlus Picks I-Bankers For Rs 2,000-Crore IPO; First By A Retail Pharmacy Chain

      Warburg Pincus and PremjiInvest-Backed MedPlus Picks I-Bankers For Rs 2,000-Crore IPO; First By A Retail Pharmacy Chain

      MedPlus is an omni-channel retailer with over 1800 stores serving over 3 lakh customers daily according to its website. It also operates online store MedPlusMart, lab testing centres MedPlus Pathlabs and surgical equipment distribution business RiteCure

    • Goldman Sachs, PremjiInvest-backed MedPlus prepares for first IPO by a pharmacy chain

      Goldman Sachs, PremjiInvest-backed MedPlus prepares for first IPO by a pharmacy chain

      Another source said MedPlus is looking to raise between Rs 800 crore and Rs 1,000 crore via the IPO

    • MedPlus on retail expansion in TN, to set up 200 stores

      MedPlus on retail expansion in TN, to set up 200 stores

      Pharmacy distributor MedPlus plansto set up 200 stores in tier II and III cities in Tamil Nadu over the next one year.

    • Fortis has renewed focus on India

      Fortis has renewed focus on India

      By selling global assets, Fortis is cutting losses but does that justify the method in its acquisition madness?

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347